Abstract
Dielectric barrier corona discharge (DBCD) is a robust plasma reactor with high efficiency and large scalable area. Nonthermal plasma is generated by DBCD in open condition under atmospheric pressure. Products of plasma are analyzed by using spectroscopy technology. The DBCD plasma is used to treat three kinds of typical microorganisms such as Escherichia coli, Staphylococcus aureus, and Candida albicans. Then, the inactivation effects of the plasma are discussed and compared with our formerly published results of parallel-plate dielectric barrier discharge (DBD) plasma. The results show that the DBCD plasma damages microbe cells by reactive species (RS) and lower pH values, while the parallel-plate DBD plasma works mainly through microdischarge channel and RS. In addition, different cell wall configurations result in different treatment effects.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
